Releasing pressure on pathology services: RFID technology has the key
With the NHS continuing to struggle as it responds to the current SARS-CoV-2 pandemic and the effects that COVID-19 disease is having on a heavy workload, Gillian Ewers examines the advantages that RFID and a transport and tracking system offer.
This story is Premium Content and is only available to registered users. Please log in to view the full text. If you don't already have an account, please register with us completely free of charge.
DiaSorin is an Italian multinational Group and a global leader in the market for in vitro diagnostics. DiaSorin is listed on the MTA (automated stock market) in the FTSE Italia Mid Cap Index, organized and managed by Borsa Italiana S.p.A
For over 40 years the Group has been developing, producing and commercializing diagnostic tests for a wide...